Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breathprinting (e-Nose) Technology for the Identification of Early-Stage Lung Cancer

NCT04734145 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT04734145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04734145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breathprinting (e-Nose) Technology for the Identification of Early-Stage Lung Cancer
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
January 25, 2021
Completion date
January 25, 2027
Enrollment
119 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung; node